In the performance report, BIOHEART-B's half-year loss narrowed to 27.213 million RMB, and no dividend will be distributed
BIOHEART (02185.HK) announced its interim results for the period ending June this year, with a revenue of RMB 20.862 million (same below). The loss narrowed to RMB 27.213 million, compared to a loss of RMB 25.83 million in the same period last year; the loss per share was RMB 0.11. No dividend was declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments